Three Munich-based healthcare startups have convinced investors to provide additional capital. Visionhealth recently closed a growth round, Inveox raised €17 million, and Kaia Health is also said to have received funding.
Inveox raises 17 million euros from existing investors.
“The magnitude of the investment not only demonstrates the trust placed in us, but also means confirmation for us that we are on the right and important path with our work,”
explained Dominik Sievert, co-founder of Inveox.
Health startups: Capital for market entry and expansion
Just last year, the medtech startup financing of five million euros The Munich-based company aims to digitize pathology laboratories to minimize misdiagnoses due to mixed-up samples. In spring 2019, the startup expanded into Germany, Austria, and Switzerland after entering the market. to PolandNow Inveox plans to expand into other countries. The company has raised millions in funding from existing investors.
Visionhealth also announced a successful financing round. The healthcare startup develops digital health solutions for respiratory diseases. The growth round is led by Sanner Ventures and a consortium of German investors, including existing investors. The investment will be used to advance product development and prepare for rapid market entry. Visionhealth aims to make respiratory therapy more efficient with artificial intelligence. Sabine Häußermann, CEO of Visionhealth, explains:
“With this new investment round, we can further expand our leading position in the digital respiratory medicine industry and act as a highly attractive partner for all those involved in the care of patients with inhalation therapies.
Kaia Health also closed a financing round, as Deutsche Startups reportedThe American healthcare investor Optum Ventures is said to have invested in the Munich-based startup. This has not yet been confirmed by the startup. Kaia aims to combat chronic back pain with its app.
